Simlandi and adalimumab-adaz have been with on formulary, along with Humira, beginning Jan. 1, 2025, Arpit Patel, Pharm.D., MedImpact vice president, Trade Relations, said in a LinkedIn video.

While multiple factors can contribute to a business closing, the additional costs Pharmacy Benefit Managers impose on ...

Tiffany Meng, PharmD, oncology pharmacist, UCSF Health, discusses ways that pharmacists can help guide patients to financial ...